Quantitative real time PCR of deoxycytidine kinase mRNA by Light Cycler PCR in relation to enzyme activity and gemcitabine sensitivity

Cancer Letters

Volumn 213, Issue 2, 2004, Pages 173-179

  Sigmond, Jennifer ^a   Kroep, Judith R ^a   Loves, Willem ^a   Codacci Pisanelli, Giovanni ^b   Peters, Godefridus J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Bladder cancer; Deoxycytidine kinase; Gemcitabine sensitivity; Light Cycler PCR

Indexed keywords

COMPLEMENTARY DNA; DEOXYCYTIDINE KINASE; GEMCITABINE; MESSENGER RNA;

ANALYTIC METHOD; ARTICLE; BLADDER TUMOR; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ESOPHAGUS TUMOR; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; NEEDLE BIOPSY; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RELIABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; STATISTICAL SIGNIFICANCE; XENOGRAFT;

ANTIMETABOLITES, ANTINEOPLASTIC; DEOXYCYTIDINE; DEOXYCYTIDINE KINASE; DNA, COMPLEMENTARY; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION PROFILING; HUMANS; LIGHT; PHOSPHORYLATION; PREDICTIVE VALUE OF TESTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; TRANSPLANTATION, HETEROLOGOUS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 3242680253     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.04.016     Document Type: Article

References (16)

1. Arner E.S., Eriksson S. Mammalian deoxyribonucleoside kinases. Pharmacol. Ther. 67:1995;155-186
2. Plagemann P.G., Marz R., Wohlhueter R.M. Transport and metabolism of deoxycytidine and 1-beta-D-arabinofuranosylcytosine into cultured Novikoff rat hepatoma cells, relationship to phosphorylation, and regulation of triphosphate synthesis. Cancer Res. 38:1978;978-989
3. Bergman A.M., Pinedo H.M., Peters G.J. Determinants of resistance to 2′,2′-difluorodeoxycytidine (gemcitabine). Drug Resist. Updat. 5:2002;19-33
4. Grant S. Ara-C: cellular and molecular pharmacology. Adv. Cancer Res. 72:1998;197-233
5. van Moorsel C.J., Peters G.J., Pinedo H.M. Gemcitabine: future prospects of single-agent and combination studies. Oncologist. 2:1997;127-134
6. Kroep J.R., Loves W.J., van der Wilt C.L., Alvarez E., Talianidis I., Boven E., et al. Pretreatment deoxycytidine kinase levels predict in vivo gemcitabine sensitivity. Mol. Cancer Ther. 1:2002;371-376
7. Crawford E.L., Peters G.J., Noordhuis P., Rots M.G., Vondracek M., Grafstrom R.C., et al. Reproducible gene expression measurement among multiple laboratories obtained in a blinded study using standardized RT (StaRT)-PCR. Mol. Diagn. 6:2001;217-225
8. Stam R.W., den Boer M.L., Meijerink J.P., Ebus M.E., Peters G.J., Noordhuis P., et al. Differential mRNA expression of Ara-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leukemia. Blood. 101:2003;1270-1276
9. Mansson E., Spasokoukotskaja T., Sallstrom J., Eriksson S., Albertioni F. Molecular and biochemical mechanisms of fludarabine and cladribine resistance in a human promyelocytic cell line. Cancer Res. 1:1999;5956-5963
10. Galmarini C.M., Clarke M.L., Falette N., Puisieux A., Mackey J.R., Dumontet C. Expression of a non-functional p53 affects the sensitivity of cancer cells to gemcitabine. Int. J. Cancer. 97:2002;239-245
11. Mansson E., Liliemark E., Soderhall S., Gustafsson G., Eriksson S., Albertioni F. Real-time quantitative PCR assays for deoxycytidine kinase, deoxyguanosine kinase and 5′-nucleotidase mRNA measurement in cell lines and in patients with leukemia. Leukemia. 16:2002;386-392
12. van der Wilt C.L., Kroep J.R., Loves W.J., Rots M.G., Van Groeningen C.J., Kaspers G.J., Peters G.J. Expression of deoxycytidine kinase in leukemic cells compared with solid tumor cell lines, liver metastases and normal liver. Eur. J. Cancer. 39:2003;691-697
13. De Berardinis E., Antonini G., Peters G.J., Loves W.J., van der Born K., Codacci-Pisanelli G., Di Silverio F. Intravesical administration of gemcitabine in superficial bladder cancer: a phase I study with pharmacodynamic evaluation. Br. J. Urol. Int. 93:2004;491-494
14. Kroep J.R., van Groeningen C.J., Cuesta M.A., Craanen M.E., Hoekstra O.S., Comans E., et al. Positron emission tomography using 2-deoxy-2-[18F]- fluoro-D-glucose for response monitoring in locally advanced gastroesophageal cancer; a comparison of different analytical methods. Mol. Imaging Biol. 5:2003;337-346
15. Rots M.G., Willey J.C., Jansen G., Van Zantwijk C.H., Noordhuis P., DeMuth J.P., et al. mRNA expression levels of methotrexate resistance-related proteins in childhood leukemia as determined by a standardized competitive template-based RT-PCR method. Leukemia. 14:2000;2166-2175
16. Willey J.C., Crawford E.L., Jackson C.M., Weaver D.A., Hoban J.C., Khuder S.A., DeMuth J.P. Expression measurement of many genes simultaneously by quantitative RT-PCR using standardized mixtures of competitive templates. Am. J. Respir. Cell Mol. Biol. 19:1998;6-17